A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/01/2011	CA2629462C Beta-secretase modulators and methods of use
11/01/2011	CA2617370C Improved cellular uptake of bioactive agents
11/01/2011	CA2605205C Polymeric pharmaceutical agent for treatment of cancer and method for production of the same
11/01/2011	CA2587023C Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
11/01/2011	CA2567110C Pet food compositions and methods
11/01/2011	CA2545644C Melanocortin receptor agonists
11/01/2011	CA2535749C Ppar activating compound and pharmaceutical composition containing same
11/01/2011	CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity
11/01/2011	CA2530487C Methods of preventing and reducing the severity of stress-associated conditions
11/01/2011	CA2523436C Quinuclidine derivatives binding to mucarinic m3 receptors
11/01/2011	CA2522028C Methods and compositions for administration of trpv1 agonists
11/01/2011	CA2521854C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
11/01/2011	CA2521621C Compounds for the treatment of metabolic disorders
11/01/2011	CA2521589C Compounds for the treatment of metabolic disorders
11/01/2011	CA2517172C Therapeutic compositions
11/01/2011	CA2513092C Compounds for the treatment of metabolic disorders
11/01/2011	CA2499825C Radiolabeled neurokinin-1 receptor antagonists
11/01/2011	CA2497535C Organic acids incorporated edible antimicrobial films
11/01/2011	CA2495826C Ant spray containing d-limonene and methods of making and using same
11/01/2011	CA2493208C Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/01/2011	CA2492976C Solution for ungual and peri-ungual application
11/01/2011	CA2492060C Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
11/01/2011	CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011	CA2490254C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/01/2011	CA2488834C Purine derivatives and their use as antiproliferative agents
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011	CA2479381C A use of treatment for fungal infections with a synergistic formulation of antifungal agent, menthol and menthyl acetate
11/01/2011	CA2479012C Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
11/01/2011	CA2476940C Pharmaceutical compositions comprising one or more steroids, one or more tetrahydrofolate components and vitamin b12
11/01/2011	CA2476683C Partial and full agonists of a1 adenosine receptors
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2475224C Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/01/2011	CA2473591C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2468826C Benzazole derivatives for the treatment of scleroderma
11/01/2011	CA2468254C Therapeutic coating for an intravascular implant
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2461662C Method and tools for oral hygiene
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011	CA2452056C Compositions of bioactive material particles dispersed in a continuous solid encapsulating material
11/01/2011	CA2448094C Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2443089C Antifungal suspension of micronized posaconazole
11/01/2011	CA2439269C Pharmaceutical salts of 1-phenyl-3-dimethylaminopropane compounds
11/01/2011	CA2434526C Methods of administering epothilone analogs for the treatment of cancer
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
11/01/2011	CA2395459C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
11/01/2011	CA2311318C Mitochondrially targeted antioxidants
11/01/2011	CA2279196C Antigenic inducer and substances prepared therefrom
11/01/2011	CA2203622C Compounds, pharmaceutical composition and diagnostic device comprising them and their use
10/2011
10/27/2011	WO2011133983A2 Reishi polysaccharide-based compositions and methods for treatment of cancer
10/27/2011	WO2011133966A2 Method and compositions for treating ace2-related disorders
10/27/2011	WO2011133963A2 Tyrosine-based prodrugs of antiviral agents
10/27/2011	WO2011133956A1 Pharmaceutical compositions and administrations thereof
10/27/2011	WO2011133953A1 Pharmaceutical compositions and administrations thereof
10/27/2011	WO2011133951A1 Pharmaceutical compositions and administrations thereof
10/27/2011	WO2011133929A2 Reducing transmission of sexually transmitted infections
10/27/2011	WO2011133920A1 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
10/27/2011	WO2011133893A2 Cyanide antidotes
10/27/2011	WO2011133889A2 NOVEL STRUCTURALLY DESIGNED shRNAs
10/27/2011	WO2011133888A1 Certain amino-pyrimidines, compositions thereof, and methods for their use
10/27/2011	WO2011133882A1 Certain amino-pyridazines, compositions thereof, and methods of their use
10/27/2011	WO2011133879A2 Combination therapies with mitochondrial-targeted anti-tumor agents
10/27/2011	WO2011133875A2 Metalloenzyme inhibitor compounds
10/27/2011	WO2011133867A2 Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
10/27/2011	WO2011133858A2 Compositions, methods of use, and methods of treatment
10/27/2011	WO2011133841A2 Intravenous omega-3 fatty acid compositions & method of use
10/27/2011	WO2011133827A2 Method of treating prostate cancer
10/27/2011	WO2011133826A2 Method for treating pancreatic cancer
10/27/2011	WO2011133819A2 Methods of enhancing antibody-dependent cellular cytotoxicity
10/27/2011	WO2011133795A2 Beta-carbolines as inhibitors of haspin and dyrk kinases
10/27/2011	WO2011133790A2 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
10/27/2011	WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011	WO2011133734A1 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists
10/27/2011	WO2011133733A1 Inhibitors of akt activity
10/27/2011	WO2011133729A2 Anti-viral compounds
10/27/2011	WO2011133728A2 Anti-viral compounds
10/27/2011	WO2011133727A2 Anti-viral compounds
10/27/2011	WO2011133722A2 Anti-viral compounds
10/27/2011	WO2011133719A2 Anti-viral compounds
10/27/2011	WO2011133712A2 Anti-viral compounds
10/27/2011	WO2011133707A2 Anti-viral compounds
10/27/2011	WO2011133696A2 Methods of suppressing atherosclerosis
10/27/2011	WO2011133692A1 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
10/27/2011	WO2011133687A2 Methods and compositions for inhibition of beta2-adrenergic receptor degradation
10/27/2011	WO2011133675A1 Gabapentin enacarbil compositions
10/27/2011	WO2011133673A1 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
10/27/2011	WO2011133668A2 Methods and compositions for the treatment of cancer
10/27/2011	WO2011133659A2 Inhibitors of hif and angiogenesis
10/27/2011	WO2011133653A1 Inhibitors of arginase and their therapeutic applications
10/27/2011	WO2011133651A1 An enantioselective process for cycloalkenyl b-substituted alanines
10/27/2011	WO2011133637A2 Compounds and methods for kinase modulation, and indications therefor
10/27/2011	WO2011133611A1 Thiazolidinedione analogues
10/27/2011	WO2011133600A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
10/27/2011	WO2011133596A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
10/27/2011	WO2011133521A2 Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
10/27/2011	WO2011133520A1 Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
10/27/2011	WO2011133511A1 Compositions of enhanced viscosity. clarity, or both enhanced viscosity and clarity
10/27/2011	WO2011133480A2 Method of treating gastric cancer

1 ... 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 ... 7860